Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa  Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa

Vector Pharma FZCO Announce Exclusive Distribution Agreement with Ascendis Pharma A/S for Skytrofa (lonapegsomatropin) and Yorvipath (palopegteriparatide) in Gulf Cooperation Council Countries  Vector Pharma FZCO Announce Exclusive Distribution Agreement with Ascendis Pharma A/S

Vector Pharma FZCO signs Exclusive License and Distribution Rights to IXEMPRA in the Middle East  DUBAI, United Arab Emirates, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Vector Pharma FZCO announced today the signing of an exclusive distribution agreement with R-PHARM US of Princeton, NJ . Under the...